Clinical changes in periodontal subjects with the probiotic Lactobacillus reuteri Prodentis: a preliminary randomized clinical trial
- PMID: 23176716
- DOI: 10.3109/00016357.2012.734404
Clinical changes in periodontal subjects with the probiotic Lactobacillus reuteri Prodentis: a preliminary randomized clinical trial
Abstract
Objectives: The aim of this study was to assess the clinical effect of the administration of Lactobacillus reuteri Prodentis as a probiotic agent in the treatment of initial to moderate chronic periodontitis. Secondary objectives were to evaluate the patient 'compliance' factor and to observe the potential side-effects of the probiotic agent.
Materials and methods: Twenty systemically healthy, non-smoking subjects with initial-to-moderate chronic periodontitis were enrolled in this 1-month double-blind, placebo-controlled, randomized clinical trial. Subjects were randomly assigned to receive tablets containing Lactobacillus reuteri Prodentis or placebo once a day for 30 days. Clinical parameters were collected at baseline and 30 days post-treatment.
Results: Periodontal clinical parameters were improved in the test group after a 30-day intervention. The test group demonstrated a statistically significant reduction (p < 0.05) in all the periodontal parameters included in the study (plaque index, bleeding on probing and pocket probing depths), while the control group treated with placebo did not show any statistically significant change in periodontal parameters.
Conclusions: These data indicate that oral administration of Lactobacillus reuteri Prodentis improved the short-term clinical outcomes in non-smoking patients with initial-to-moderate chronic periodontitis.
Similar articles
-
Probiotic effects of orally administered Lactobacillus salivarius WB21-containing tablets on periodontopathic bacteria: a double-blinded, placebo-controlled, randomized clinical trial.J Clin Periodontol. 2009 Jun;36(6):506-13. doi: 10.1111/j.1600-051X.2009.01392.x. Epub 2009 Apr 22. J Clin Periodontol. 2009. PMID: 19453574 Clinical Trial.
-
Improvement of periodontal condition by probiotics with Lactobacillus salivarius WB21: a randomized, double-blind, placebo-controlled study.J Clin Periodontol. 2008 Oct;35(10):897-905. doi: 10.1111/j.1600-051X.2008.01306.x. Epub 2008 Aug 24. J Clin Periodontol. 2008. PMID: 18727656 Clinical Trial.
-
Effect of the probiotic Lactobacilli reuteri (Prodentis) in the management of periodontal disease: a preliminary randomized clinical trial.J Oral Microbiol. 2010 Nov 2;2. doi: 10.3402/jom.v2i0.5344. J Oral Microbiol. 2010. PMID: 21523225 Free PMC article.
-
Methodological issues in randomized trials assessing probiotics for periodontal treatment.J Periodontal Res. 2012 Feb;47(1):15-26. doi: 10.1111/j.1600-0765.2011.01399.x. Epub 2011 Jul 21. J Periodontal Res. 2012. PMID: 21777405 Review.
-
The role of probiotic bacteria in managing periodontal disease: a systematic review.Expert Rev Anti Infect Ther. 2016 Jul;14(7):643-55. doi: 10.1080/14787210.2016.1194198. Epub 2016 Jun 3. Expert Rev Anti Infect Ther. 2016. PMID: 27224284 Review.
Cited by
-
Periodontitis Continuum: Antecedents, Triggers, Mediators, and Treatment Strategies.Curr Med Chem. 2024;31(41):6775-6800. doi: 10.2174/0109298673265862231020051338. Curr Med Chem. 2024. PMID: 39428847 Review.
-
Probiotics in the non-surgical treatment of periodontitis: a systematic review and network meta-analysis.BMC Oral Health. 2024 Oct 15;24(1):1224. doi: 10.1186/s12903-024-05027-6. BMC Oral Health. 2024. PMID: 39407177 Free PMC article.
-
The Potential Impact of Probiotics on Human Health: An Update on Their Health-Promoting Properties.Microorganisms. 2024 Jan 23;12(2):234. doi: 10.3390/microorganisms12020234. Microorganisms. 2024. PMID: 38399637 Free PMC article. Review.
-
Periodontal disease in down syndrome: Predisposing factors and potential non-surgical therapeutic approaches.J Clin Lab Anal. 2024 Jan;38(1-2):e25002. doi: 10.1002/jcla.25002. Epub 2024 Jan 22. J Clin Lab Anal. 2024. PMID: 38254289 Free PMC article. Review.
-
Effect of adjuvant probiotic therapy (Lactobacillus reuteri) in the treatment of periodontitis associated with diabetes mellitus: clinical, controlled, and randomized study.Clin Oral Investig. 2024 Jan 6;28(1):80. doi: 10.1007/s00784-023-05441-0. Clin Oral Investig. 2024. PMID: 38183505 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources